Back to Main

Faculty Detail    
Name C. RYAN MILLER
MD, PhD
 
Campus Address WTI 410C Zip 3300
Phone  (205) 934-7320
E-mail  rmiller@uab.edu
Other websites
     

Education
Undergraduate  Vanderbilt University    1992  BA, Mathematics and Chemistry 
Graduate  University of Alabama at Birmingham    1999  PhD, Molecular and Cellular Pathology 
Medical School  University of Alabama School of Medicine    2002  MD 
Residency  Washington University in St. Louis    2004  Anatomic Pathology 
Fellowship  Washington University in St. Louis    2006  Neuropathology 

Certifications
North Carolina Medical Board (2007-00149)  2007 
Alabama Medical Licensure Commission (L.4915SP)  2019 


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Clinical Pathology  Neuropathology Professor
Center  Alzheimer's Disease Center  Alzheimer's Disease Center Professor
Center  Comprehensive Cancer Center  Comprehensive Cancer Center Professor
Center  Comprehensive Neuroscience Center  Comprehensive Neuroscience Center Professor
Center  Ctr for Clinical & Translational Sci  Ctr for Clinical & Translational Sci Professor

Society Memberships
Organization Name Position Held Org Link
American Association for Cancer Research (AACR)    https://www.aacr.org/Pages/Home.aspx 
American Association of Neuropathologists (AANP)  Chair, Constitution Committee  http://www.neuropath.org/ 
American Society for Investigative Pathology (ASIP)    https://www.asip.org/ 
American Society of Clinical Oncology (ASCO)    https://www.asco.org/ 
College of American Pathologists (CAP)    http://www.cap.org/ 
Histochemical Society (HCS)    http://histochemicalsociety.org/ 
Society for Neuro-Oncology (SNO)    http://www.soc-neuro-onc.org/ 
United States and Canadian Academy of Pathology (USCAP)    http://www.uscap.org/ 



Research/Clinical Interest
Title
Glioma pathogenesis and preclinical experimental therapeutics
Description
My clinical, translational, and basic research focuses on the most common and malignant primary brain tumors, gliomas. We use cutting-edge mouse models, human models and tissues, and molecular, genetic, neurobiological, genomic, and proteomic approaches to dissect the effect of cellular origin, intracellular signaling networks, and tumor microenvironment on malignant glioma biology.

Keywords
glioma, glioblastoma, mouse models, genomics, proteomics